Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
deal
Biotech
Lisata lays off 72% of staffers, sues Kuva after merger folds
Lisata is laying off 72% of its workforce, including its chief medical officer, after a merger with cancer imaging company Kuva Labs fell apart.
Marissa Russo
Aug 4, 2026 9:37am
Dimerix buys Mission’s kidney disease prospect in $292M deal
Jul 17, 2026 5:00am
Olympus pushes deeper into oncology with $270M BioProtect deal
May 26, 2026 3:57pm
Astellas, Dyno unearth $15M muscle disorder capsid
Apr 8, 2026 8:00am
China biotechs ‘reshaping’ US biopharma: Jefferies report
Jul 14, 2025 2:30pm
US biotech finds Relief via reverse merger
Nov 4, 2024 1:05pm